title: A rat model of chronic allograft liver rejection.
abstract: BACKGROUND
  The aim of this study was to develop a rat model of chronic irreversible rejection, which is a major causes of late graft loss and retransplantation after orthotopic liver allotransplantation.
  
  
  METHODS
  Allogeneic liver transplantation was performed in a rat combination of Dark Agouti (DA) to Brown Norway (BN). Group A was left without treatment, group B received cyclosporine' (CsA; 1 mg/kg/d) and group C, CsA (4 mg/kg/d). Animals were followed for 6 months. Liver tissue was harvested to construct a time course of histological changes after liver transplantation using histopathological and morphometric techniques. We compared the total histological score of rejection activity index and survival rates.
  
  
  RESULTS
  In untreated animals, irreversible acute rejection developed, all animals died within 15 days. In the low-dose CsA group, all animals that survived more than 30 days developed moderate to severe manifestations of chronic liver rejection, with graft infiltration, ductular damage or proliferation, obliterative arteriopathy, and liver fibrosis. No apparent histological alterations were observed in group C. Survival analysis showed significant differences between the three groups.
  
  
  CONCLUSIONS
  In the rat strain combination of DA --> BN with low-dose immunosuppression, early mild inflammation was followed by the development of chronic rejection.
authors.affiliation: Dept of Hepatobiliary and Pancreatic Surgery, Key Lab of Combined Multi-Organ Transplantation, Ministry of Public Health, First Affiliated Hospital, Zhejiang University School of Medicine, Qingchun Road, 79 Hangzhou 310003, People's Republic of China.
authors.forename: L H
authors.initials: LH
authors.lastname: Gao
authors.forename: S S
authors.initials: SS
authors.lastname: Zheng
authors.forename: Y F
authors.initials: YF
authors.lastname: Zhu
authors.forename: Y L
authors.initials: YL
authors.lastname: Wan
authors.forename: Y L
authors.initials: YL
authors.lastname: Wang
authors.forename: G Q
authors.initials: GQ
authors.lastname: Wei
authors.forename: S K
authors.initials: SK
authors.lastname: Qian
authors.forename: S Q
authors.initials: SQ
authors.lastname: Qian
authors.forename: W J
authors.initials: WJ
authors.lastname: Jiang
mesh_terms: D000818:Animals; D016572:Cyclosporine / Q000627:therapeutic use; D004195:Disease Models, Animal; D006084:Graft Rejection / Q000401:mortality / Q000473:pathology* / Q000517:prevention & control; D016031:Liver Transplantation / Q000276:immunology / Q000401:mortality / Q000473:pathology*; D051381:Rats; D011914:Rats, Inbred BN; D011919:Rats, Inbred Strains
chemical_list: D016572:Cyclosporine